M. Salah Shurbaji
M. Salah Shurbaji, M.D.
Medical Director, Pathology Laboratory
Director, Pathology ResidencyProgram
BS, American University of Beirut, Beirut, Lebanon
MS, American University of Beirut, Beirut, Lebanon
MD, American University of Beirut, Beirut, Lebanon
Residency: Johns Hopkins Hospital
Postdoctoral Research Fellowship: Johns Hopkins University School of Medicine
Anatomic and Clinical Pathology, American Board of Pathology
Cytopathology, American Board of Pathology
Genitourinary Pathology, Surgical pathology, and Cytopathology
Burja IT, Shurbaji MS. The clinical impact of identifying Trichomonas vaginalis on cervicovaginal (Pap) smears. Diagn Cytopathol. 24:195-199, 2001.
Shurbaji MS, Burja IT, Sawyer WL. Clinical significance of identifying Candida on cervicovaginal (Pap) smears. Diagn Cytopathol. 21:14-17, 1999.
Burja IT, Thompson SK, Sawyer WL, Shurbaji MS. Atypical glandular cells of undetermined significance (AGUS) on cervical smears: A study with cytohistologic correlation. Acta Cytol. 43:351-356, 1999.
Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression in prostate cancer. Hum Pathol 27:917-921, 1996.
Shurbaji MS, Kalbfleisch, JH, Thurmond TS. Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer. Hum Pathol, 26:106-109, 1995.